Dr. Petr Dzubak is a scientist and paediatrician specialising in molecular and translational medicine, with a focus on oncology and infectious diseases. He leads the Chemical Biology and Experimental Therapeutics research programme at IMTM. He has actively participated in the research of more than 20 national and international projects and is a member of the advisory board of the Cancer Research Foundation ‘Rakovina ve Veřejnost’. He is also a co-founder of a spin-off company focused on the manufacture of molecular diagnostics. He has published over 140 papers and books/chapters and has received over 3552 SCI citations. His H-index is 27 and he won the Prix de Pharmacie 2007 Ambassade de France—Sanofi-aventis Premier Prix. His research interests include molecular and translational medicine, oncology, drug research and development, MOA and drug resistance.